SARS-CoV-2 and Other Respiratory Viruses: What Does Oxidative Stress Have to Do with It? DOI Creative Commons
Iara Grigoletto Fernandes, Cyro Alves de Brito, Vitor Manoel Silva dos Reis

et al.

Oxidative Medicine and Cellular Longevity, Journal Year: 2020, Volume and Issue: 2020, P. 1 - 13

Published: Dec. 21, 2020

The phenomenon of oxidative stress, characterized as an imbalance in the production reactive oxygen species and antioxidant responses, is a well-known inflammatory mechanism constitutes important cellular process. relationship viral infections, production, antiviral response relevant. Therefore, aim this review to report studies showing how may positively or negatively affect pathophysiology infection. We focus on known respiratory especially severe acute syndrome coronaviruses (SARS-CoVs), attempt provide information challenges posed by current COVID-19 pandemic. Because therapies for (e.g., SARS-CoV-2) are rare, knowledge about relevant compounds pathways be understanding pathogenesis identifying possible therapeutic targets.

Language: Английский

Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis DOI Creative Commons
Oriana D’Ecclesiis,

Costanza Gavioli,

Chiara Martinoli

et al.

PLoS ONE, Journal Year: 2022, Volume and Issue: 17(7), P. e0268396 - e0268396

Published: July 6, 2022

To assess the evidence on SARS-CoV2 infection and Covid-19 in relation to deficiency supplementation of vitamin D, we conducted a systematic review up April 2021. We summarised data from 38 eligible studies, which presented risk estimates for at least one endpoint, including two RCT 27 cohort-studies: 205565 patients with information 25OHD status 2022 taking D total 1197 admitted ICU or who needed invasive mechanical ventilation intubation hospital stay, more than 910 deaths. Primary outcomes were severity mortality main aim was evaluate association supplementation. Random effects models showed that associated significant lower both severe disease (SRR 0.38, 95% CI 0.20-0.72, 6 studies) 0.35, 0.17-0.70, 8 studies). There no statistically dose differences between studies: summary regular doses remain significant, suggesting higher are not necessary. For supplementation, greater reduction emerged older individuals latitudes. Regarding quality assessed using New Castle-Ottawa scale, analysis revealed most cases low, medium high studies. found associations Covid-19, encompassing risks worsening mortality, especially seasons characterized by patients. Dedicated randomized clinical studies encouraged confirm these results.

Language: Английский

Citations

71

A Global Overview of Dietary Supplements: Regulation, Market Trends, Usage during the COVID-19 Pandemic, and Health Effects DOI Open Access
Ouarda Djaoudene, Anabela Romano,

Yasmine Djedjiga Bradai

et al.

Nutrients, Journal Year: 2023, Volume and Issue: 15(15), P. 3320 - 3320

Published: July 26, 2023

Over the last 20 years, use of dietary supplements (DS) has continued to grow in many countries. Due public health crisis brought on by COVID-19 pandemic and amidst fears regarding vaccines their low supply regions world, there been a marked interest DS as alternative means protecting against treating this emerging disease, well boosting immune system minimizing risk inflammation. Despite lack evidence suggest efficacy, surge sales reported parts world. Questions have also raised about effects associated with due increased during crisis. Numerous scientific studies demonstrated beneficial properties some adverse even toxic effects. In addition, given current global issue, review is needed establish status before The aim summarize impact incidence pandemic, regulation market trends. First, we provide an overview DS, including comprehensive legislative regulatory aspects USA, China, EU, Algeria. Second, describe prevalence most commonly consumed efficacy prophylactic modality era COVID-19. Additionally, examine structure size countries that predominantly produce import them, its trend, growth. Finally, review, discuss profile users.

Language: Английский

Citations

66

COVID-19 Disease Severity and Death in Relation to Vitamin D Status among SARS-CoV-2-Positive UAE Residents DOI Open Access
Habiba Alsafar, William B. Grant, Rafiq Hijazi

et al.

Nutrients, Journal Year: 2021, Volume and Issue: 13(5), P. 1714 - 1714

Published: May 19, 2021

Insufficient blood levels of the neurohormone vitamin D are associated with increased risk COVID-19 severity and mortality. Despite global rollout vaccinations promising preliminary results, focus remains on additional preventive measures to manage COVID-19. Results conflict D's plausible role in preventing treating We examined relation between status mortality among multiethnic population United Arab Emirates. Our observational study used data for 522 participants who tested positive SARS-CoV-2 at one main hospitals Abu Dhabi Dubai. Only 464 those patients were included analysis. Demographic clinical retrospectively analyzed. Serum samples immediately drawn first hospital visit measure serum 25-hydroxyvitamin [25(OH)D] concentrations through automated electrochemiluminescence. Levels < 12 ng/mL significantly higher severe infection death. Age was only other independent factor, whereas comorbidities smoking did not contribute outcomes upon adjustment. Sex an important predictor or is conducted UAE 25(OH)D SARS-CoV-2-positive confirm association

Language: Английский

Citations

86

The role of vitamin D in the age of COVID‐19: A systematic review and meta‐analysis DOI Open Access
Roya Ghasemian, Amir Shamshirian, Keyvan Heydari

et al.

International Journal of Clinical Practice, Journal Year: 2021, Volume and Issue: 75(11)

Published: July 29, 2021

Evidence recommends that vitamin D might be a crucial supportive agent for the immune system, mainly in cytokine response regulation against COVID-19. Hence, we carried out systematic review and meta-analysis order to maximise use of everything exists about role

Language: Английский

Citations

85

COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis DOI Open Access
Lorenz Borsche, Bernd Glauner, Julian von Mendel

et al.

Nutrients, Journal Year: 2021, Volume and Issue: 13(10), P. 3596 - 3596

Published: Oct. 14, 2021

Much research shows that blood calcidiol (25(OH)D3) levels correlate strongly with SARS-CoV-2 infection severity. There is open discussion regarding whether low D3 caused by the or if deficiency negatively affects immune defense. The aim of this study was to collect further evidence on topic.

Language: Английский

Citations

76

Vitamin D: A Role Also in Long COVID-19? DOI Open Access
Luigi Barrea, Ludovica Verde, William B. Grant

et al.

Nutrients, Journal Year: 2022, Volume and Issue: 14(8), P. 1625 - 1625

Published: April 13, 2022

Coronavirus disease 2019 (COVID-19) has quickly become a global pandemic. Reports from different parts of the world indicate that significant proportion people who have recovered COVID-19 are suffering various health problems collectively referred to as "long COVID-19". Common symptoms include fatigue, shortness breath, cough, joint pain, chest muscle aches, headaches, and so on. Vitamin D is an immunomodulatory hormone with proven efficacy against upper respiratory tract infections. can inhibit hyperinflammatory reactions accelerate healing process in affected areas, especially lung tissue. Moreover, vitamin deficiency been associated severity mortality cases, high prevalence hypovitaminosis found patients acute failure. Thus, there promising reasons promote research into effects supplementation patients. However, no studies date affects post-COVID-19 or biomarkers. Based on this scenario, review aims provide up-to-date overview potential role long current literature topic.

Language: Английский

Citations

68

Does vitamin D supplementation reduce COVID-19 severity?: a systematic review DOI Open Access
Komal Shah,

V P Varna,

Uma Sharma

et al.

QJM, Journal Year: 2022, Volume and Issue: 115(10), P. 665 - 672

Published: Feb. 9, 2022

The evidence regarding the efficacy of vitamin D supplementation in reducing severity COVID-19 is still insufficient. This partially due to lack primary robust trial-based data and heterogeneous study designs.

Language: Английский

Citations

65

Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D DOI Open Access
Ming-Yieh Peng,

Wen-Chih Liu,

Jing-Quan Zheng

et al.

International Journal of Molecular Sciences, Journal Year: 2021, Volume and Issue: 22(10), P. 5251 - 5251

Published: May 16, 2021

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is still an ongoing global health crisis. Immediately after the inhalation of SARS-CoV-2 viral particles, alveolar type II epithelial cells harbor and initiate local innate immunity. These particles can infect circulating macrophages, which then present coronavirus antigens to T cells. Subsequently, activation differentiation various types cells, as well uncontrollable cytokine release (also known storms), result in tissue destruction amplification immune response. Vitamin D enhances immunity required for combating COVID-19 activating toll-like receptor 2. It also antimicrobial peptide synthesis, such through promotion expression secretion cathelicidin β-defensin; promotes autophagy autophagosome formation; increases synthesis lysosomal degradation enzymes within macrophages. Regarding adaptive immunity, vitamin CD4

Language: Английский

Citations

62

Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study DOI
Marco Infante, Andrea Buoso, Massimo Pieri

et al.

Journal of the American Nutrition Association, Journal Year: 2021, Volume and Issue: 41(3), P. 250 - 265

Published: Feb. 18, 2021

Objective Preliminary findings suggest a relationship between lower serum 25-hydroxyvitamin D [25(OH)D] levels and incidence severity of COVID-19. The aim this study was to evaluate the vitamin status at admission different markers inflammation, coagulation, sepsis in hospitalized patients with

Language: Английский

Citations

58

The Impact of Vitamin D Level on the Severity and Outcome of Hospitalized Patients with COVID-19 Disease DOI Creative Commons
Dania Alkhafaji, Reem Al Argan, Waleed Albaker

et al.

International Journal of General Medicine, Journal Year: 2022, Volume and Issue: Volume 15, P. 343 - 352

Published: Jan. 1, 2022

The world is experiencing a life-altering and extraordinary situation in response to the COVID-19 pandemic. There are limited data controversies regarding relationship between vitamin D (Vit D) status disease. Thus, this study was designed investigate association Vit levels severity or outcomes of

Language: Английский

Citations

52